About
Suzanne Hendrix, PhD is CEO of Pentara Corporation, a boutique CRO focused on statistics and data management in neurodegenerative diseases, especially Alzheimer’s disease. She also serves as an advisor to Propel Bio Partners and has contributed extensively to clinical-trial design, regulatory strategy, and biostatistical methodology, with more than 150 peer-reviewed publications. Public sources also note her collaboration with the World Health Organization on intrinsic-capacity measurement in aging.
Areas of interest
biotechneuroscienceAlzheimer's diseaseneurodegenerative diseasesclinical trialsbiostatisticsregulatory sciencedrug developmenthealthy aging